Medical Properties Trust reports Q1 results today — April 30 — and it arrives at the print carrying one of the highest short scores in the REIT universe, even as short sellers have been quietly trimming positions this month.
The most significant tension entering the release is the gap between the ORTEX short score and the direction of short interest itself. The short score holds at 81.9, well into high-conviction-bear territory and barely off the recent peak. Yet short interest has declined 5.1% over the past week to 22.4% of free float, pulling back from a high of roughly 23.6% in mid-April. Positions built through the first half of the month have been unwound ahead of the catalyst — but at 22.4% of float, this remains one of the most heavily shorted names in the Healthcare REIT space.
The lending market has loosened noticeably, which supports the read that bears are stepping back rather than pressing. Availability, at around 121% of outstanding short interest, means supply of borrowable shares is running well above the amount currently shorted — a far cry from the squeeze-prone setups seen last summer when availability was far tighter and the 52-week utilisation peak hit 85%. Cost to borrow has also retreated hard from its March highs: CTB briefly topped 1.3% in late March but has since halved to around 0.74%, reflecting the reduced urgency among short sellers. Options positioning echoes this measured tone — the put/call ratio is running at 0.96, only marginally above its 20-day average of 0.95 and just 0.6 standard deviations elevated. The options market is not flashing alarm ahead of today's print.
The Street remains divided, and analyst coverage is thin enough that a single move carries real weight. The only recent change on record was RBC Capital raising its target from $4.50 to $5.00 in early March — a modest upgrade to a Sector Perform rating rather than a ringing endorsement. The mean price target across the coverage set stands around $5.86, implying about 14% upside from the current $5.13. The bull case rests on an AFFO recovery toward $0.64 per share as tenant stress normalises and non-performing assets are monetised. Bears point to a projected 37.8% FFO decline in 2025 and the risk that asset sales become necessary to manage debt maturities in late 2026 and into 2027 — with AFFO potentially settling as low as $0.36 per share if tenant recoveries disappoint. The EV/EBITDA multiple of 14.1x is roughly in line with distressed-REIT comps and has been relatively stable over the past 30 days, which tells you the market is waiting on the fundamental update rather than re-rating the name.
The insider picture adds texture but not conviction. On April 8, the CEO Edward Aldag sold 109,433 shares at $4.67 — around $511,000 in value — alongside simultaneous sales by the CFO and several SVPs. A similar cluster of insider sales occurred in January at $5.04. The trades carry a significance score of just 1 out of 10, suggesting these are likely pre-scheduled disposals rather than urgent exits, but the optics of senior management selling on both sides of the stock's range underline why the institutional community is cautious. BlackRock and Vanguard together hold nearly 24% of shares, largely steady, which anchors the float but provides no directional signal.
The two most recent earnings reactions provide a mixed baseline: MPT fell 2.8% the day after February's Q3 print, then gave back 5.9% over the following week; but the Q4 release in February sparked a 5.4% gain on the day and extended to +8.2% over five sessions. With short interest still elevated and a high short score, the setup is asymmetric — a strong operational update could accelerate the covering trend already underway, while a miss or softer guidance on tenant cash flows would test whether the recent pullback in shorts was premature. What matters most today is whether MPT's management can show credible progress on the tenant recovery narrative that underpins the bull case.
See the live data behind this article on ORTEX.
Open MPT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
